|

April 2008
David S. Lester, PhD, Senior VP of Strategy and
Corporate Development speaks out on the future of Pharma.
April 21-23 2008
Larissa G. Karnaoukhova, PhD, Director, Strategic Partnerships West
Coast, will present a report at the 4th Annual Quantitative PCR meeting
entitled: FDA/ICH Analytical Method Validation for Genomic Transcript
Abundance by Standardized Reverse Transcriptase PCR using a Standard
Mixture of Internal Standards. San Diego, CA.
www.healthtech.com
April 12-16 2008
Dr. James C. Willey, Founder and
Chief Science and Medical Consultant, is speaking at the American
Association for Cancer Researchs Annual Meeting in San Diego, CA.
www.aacr.org
March 25-28 2008
David S. Lester, PhD, Senior VP
of Strategy and Corporate Development will be at the Molecular Medicine
Tri-Conference heading up an expert panel on: Putting Personalized
Medicine into Clinical Practice: Perspectives from the Stakeholders. San
Francisco, CA.
www.tri-conference.com
March 25-26 2008
Larissa G. Karnaoukhova, PhD,
Director, Strategic Partnerships West Coast, represents GEI at the
American Association for Clinical Chemistrys San Diego conference:
Genomic Technologies at the Interface of Diagnostics & Therapeutics.
Come visit our booth!
www.aacc.org
March 9-11 2008
David S. Lester, PhD, Senior VP
of Strategy and Corporate Development, is a featured speaker at the
Pharmaceutical Marketing and Research Groups Annual Conference in
Phoenix, AZ.
www.pmrg.org
September 17-20th, 2007
Dr. James
C. Willey, M.D., Founder and Chief Science & Medical Consultant to GEI, will
present an abstract at the annual AACR (American Association for Cancer
Research) Molecular Diagnostics in Cancer Therapeutic Development conference
held in Atlanta, Georgia, September 17-20. The abstract focuses on a
potential biomarker for lung cancer that Dr. Willey and his colleagues at
the University of Toledo have been working on.
|